Oral hairy leukoplakia as an early indicator of Epstein-Barr virus-associated post-transplant lymphoproliferative disorder

Journal of Oral and Maxillofacial Surgery

Volumn 60, Issue 8 SUPPL. 1, 2002, Pages 948-950

  Casiglia, Jeffrey ^a   Woo, Sook Bin ^a  

^a HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE MARKER; DISEASE PREDISPOSITION; EARLY DIAGNOSIS; EPSTEIN BARR VIRUS; HUMAN; LEUKOPLAKIA; LYMPHOPROLIFERATIVE DISEASE; MALE; PROGNOSIS;

EID: 0036338707     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1053/joms.2002.33870     Document Type: Article

References (16)

1. Oral "hairy" leucoplakia in male homosexuals: Evidence of association with both papillomavirus and a herpes-group virus
2. Oral hairy leukoplakia among HIV-positive intravenous drug abusers: A clinicopathologic and ultrastructural study
3. Oral hairy leukoplakia in an HIV-negative renal transplant recipient
4. Hairy leukoplakia after bone marrow transplantation
5. Oral hairy leukoplakia in nonimmunosuppressed patients: Report of four cases
6. Incidental oral hairy leukoplakia in immunocompetent persons: A report of two cases
7. Hairy leukoplakia: An AIDS-associated opportunistic infection
8. Lymphoproliferative disorders after organ transplantation: A report of 24 cases observed in a single center
9. Posttransplant lymphoproliferative disease in thoracic organ transplant patients: Ten years of cyclosporine-based immunosuppression
10. Are post-transplant lymphomas inevitable?
11. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients
12. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients
13. Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor for posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations
14. Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy
15. Treatment of Epstein-Barr virus-induced posttransplantation lymphoproliferative disorder with foscarnet alone in an adult after simultaneous heart and renal transplantation
16. Epstein-Barr virus (EBV) load in bone marrow transplant recipients at risk to develop posttransplant lymphoproliferative disease: Prophylactic infusion of EBV-specific cytotoxic T cells